Supply Issues Becton Dickinson UK Ltd Stock Oxford Blood Gas Syringe FWC082 (ICN 2962)

• The supply issue with Blood Gas Syringe products from Becton Dickinson is now resolved.
• FWC082 is now available to order through our online catalogue.
• This ICN is now closed.

Change:

• The supplier Becton Dickinson has informed us of a supply issue with its Blood Gas Syringe products.
• One product code is affected:
  • FWC082 – Blood Gas Syringe Without Needle 1ml no needle plus a line slip tip contains 30/50 IU of Spray dried Calcium-balanced Lithium heparin.
• The supply issue is due to increased demand and lead times; demand has outstripped supply.
• Due to this ongoing supply issue this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• FWC082 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• A potential indirect alternative product is available to order through our online catalogue:
  • FWC086 – Blood Gas Syringe Without Needle – 1ml no needle preset slip tip contains 30/50 IU of Spray dried Calcium-balanced Lithium heparin.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternative.
• The supply issue is anticipated to be resolved by 18 July 2025.

Next Steps:              

• Customers are advised to log into our website to view the product listing for further information on the affected product code and potential alternative and to view the product code currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.